AMLX Jan 2025 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 04:24PM EDT. Market open.
| Previous close | 0.1000 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 2.7500 |
| Strike | 30.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0500 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 93 |
GuruFocus.comAmylyx Pharmaceuticals Reports Q1 2024 Financial Results
Significant Revenue Growth Amidst Strategic Shifts and Clinical Developments
Insider MonkeyAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript May 9, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24. AMLX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
ZacksAmylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
Amylyx Pharmaceuticals (AMLX) delivered earnings and revenue surprises of -291.67% and 21.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.